Important: Hydroxycut Class Action Have Already Been Reported
On May 1, 2009, there had been a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that people using the products were developing major liver problems and other health concerns. Less than 7 days later, on May 4, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company neglectfulness in informing the public about potential hazards of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action court action is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less dear, than filing an individual suit. As a rule, filing a class action legal action will not cost you anything unless there’s a settlement. At that time, the attorney who handled the suit will take his charges from the compensation that was given and then distribute the remaining funds to the accusers in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action lawsuits have become so popular.
The 1st class action legal action against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall happened in the US where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning people who sustained respiration, neurological, cardiovascular, and gut issues as a result of Canadians using the products.
The Hydroxycut Lawsuit alleges that the company sold the products without properly informing the public of the health risks that they could exposing shoppers to. The complaint states the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to allege that this was a blatant omission on the part of the company which deliberately misled buyers concerning the protection of the products.
